Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.14 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’
Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry. 
Via Stocktwits
Topics Economy Government Lawsuit
These S&P500 stocks are the most active in today's session
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session. 
Via Chartmill
What's Going On With Kenvue Stock Tuesday?
Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with... 
Via Benzinga
Topics Government
Why Is Kenvue Stock Rising Today?
Via Stocktwits
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish
Via Stocktwits
Topics Government
Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease
Via Stocktwits
Topics Government
Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report
Via Stocktwits
Kenvue On Track To Bounce Back From Record Lows — What’s Driving Stock Higher In Premarket?
Many doctors reportedly disagreed with the Trump administration’s Tylenol claims and warned that these unfounded claims would likely impair maternal health. 
Via Stocktwits
Topics Government Lawsuit
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade—Kenvue, Micron Tech, Nvidia In Focus
U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism
Jim Cramer says Trump creates a "nightmare" for Kenvue after linking Tylenol to autism. Learn why KVUE stock is plunging amid lawsuit fears. 
Via Benzinga
Topics Government Lawsuit
Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records
Tech did the heavy lifting as Nvidia and Apple dragged indexes over the finish line; gold hit yet another all-time high while oil sagged. The Fed chorus grew louder and more discordant. 
Via Chartmill
Topics Economy
What 8 Analyst Ratings Have To Say About Kenvue
 
Via Benzinga
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check?
Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks. 
Via Stocktwits
Topics Government
Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54. 
Via Benzinga
Topics Stocks
Which S&P500 stocks are moving on Monday?
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
Curious about the most active S&P500 stocks in today's session?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest... 
Via Chartmill
Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday?
Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts. 
Via Benzinga
Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off?
Shares of Kenvue Inc (NASDAQ: KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products. 
Via Benzinga
Topics Government
Top S&P500 movers in Monday's session
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Which S&P500 stocks are gapping on Monday?
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
What's going on in today's pre-market session: S&P500 movers
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report
Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority. 
Via Benzinga
Topics Government
Kenvue, J&J Retail Traders Cautious As US Health Officials Reportedly Plan To Announce Tylenol Links To Autism
Tylenol is one of the most common medicines for reducing pain and fever, and a major product for Kenvue. 
Via Stocktwits
Topics Government
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement... 
Via MarketMinute
Topics Bankruptcy Death Lawsuit
Jim Cramer's Warning On This Oil Stock: 'You Don't Want To Be In It'
Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tankers, Occidental Petroleum, and Kenvue on CNBC's Mad Money Lightning Round. 
Via Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report
Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and autism. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.